Sevil B. Alieva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sevil B. Alieva has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Zaderenko Igor Alexandrovich
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
11 shared publications - Tatiana N. Borisova
N.N. Blokhin National Medical Research Center of Oncology
7 shared publications - Ali M. Mudunov
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies; Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
6 shared publications - Valeria V. Glebovskaya
N.N. Blokhin National Medical Research Center of Oncology
6 shared publications - M. A. Kropotov
National Medical Research Radiological Centre, Ministry of Health of Russia
5 shared publications - Oxana P. Trofimova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
5 shared publications
Latest Publications
- 26 June 2026
- Published by Publishing House ABV Press in Supportive Therapy in Oncology
- Vol. 3 (1) , 43-50
Management of patients with head and neck cancer undergoing radiation or chemoradiation therapy: from prevention to monitoring
Radiation therapy is a widely used treatment for head and neck cancer, used alone or in combination with chemotherapy or surgery. Despite its effectiveness, radiation therapy is often associated with undesirable side effects. Some oral complications develop soon after the start of treatment, while others may appear months or even years after completion of therapy. This article presents integrated approaches to managing patients with head and neck tumors that improve treatment outcomes and patient quality of life. Integrative, symptom-based approaches may improve patient outcomes; however, data on their use and impact in real-world clinical practice are still limited. This article presents preventive and therapeutic measures and provides treatment recommendations.
- 26 June 2026
- Published by Publishing House ABV Press in Supportive Therapy in Oncology
- Vol. 3 (1) , 43-50
Management of patients with head and neck cancer undergoing radiation or chemoradiation therapy: from prevention to monitoring
Radiation therapy is a widely used treatment for head and neck cancer, used alone or in combination with chemotherapy or surgery. Despite its effectiveness, radiation therapy is often associated with undesirable side effects. Some oral complications develop soon after the start of treatment, while others may appear months or even years after completion of therapy. This article presents integrated approaches to managing patients with head and neck tumors that improve treatment outcomes and patient quality of life. Integrative, symptom-based approaches may improve patient outcomes; however, data on their use and impact in real-world clinical practice are still limited. This article presents preventive and therapeutic measures and provides treatment recommendations.
- Open Access
- 9 June 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 16 (1) , 27-37
Adenoid cystic cancer of nasopharynx: a single-institution retrospective study
Introduction. Adenocystic nasopharyngeal carcinoma is a rare but highly aggressive malignancy arising from the tissue of the minor salivary glands. Currently, there is no consensus in the medical community regarding the optimal treatment method. The priority of surgery over radiation therapy, as well as the advisability of monotherapy versus combination approaches, remain controversial. Aim. To summarize the clinical characteristics of adenocystic nasopharyngeal carcinoma based on an analysis of 13 cases from a single institution, with the aim of optimizing therapeutic approaches for treating patients with these rare tumors. Materials and methods. A retrospective analysis of data from 13 patients with nasopharyngeal adenocarcinoma treated at the N. N. Blokhin National Medical Research Center of Oncology from 1989 to 2023 was conducted. All patients underwent conservative chemoradiation therapy: in 6 cases – concurrent chemoradiation therapy, in 7 cases – induction chemotherapy followed by radiation or chemoradiation. Results. A complete clinical effect was achieved in 9 patients, a partial effect in 4. Disease progression was noted in 7 cases: local recurrence in 3 patients, continued tumor growth in 1, distant metastases in 3. The five-year survival rate was 38.5 %. Five patients died during the first two months, another three were lost to follow-up 5–15 months after the start of treatment. The median overall survival was 28 months. Conclusion. Adenoid cystic carcinoma of the nasopharynx is an extremely rare pathology. Although the standard treatment is surgery followed by radiation therapy, when radical surgery is not possible in patients with locally advanced disease, chemoradiation therapy becomes the treatment of choice.
- 9 June 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 16 (1) , 27-37
Open AccessAdenoid cystic cancer of nasopharynx: a single-institution retrospective study
Introduction. Adenocystic nasopharyngeal carcinoma is a rare but highly aggressive malignancy arising from the tissue of the minor salivary glands. Currently, there is no consensus in the medical community regarding the optimal treatment method. The priority of surgery over radiation therapy, as well as the advisability of monotherapy versus combination approaches, remain controversial. Aim. To summarize the clinical characteristics of adenocystic nasopharyngeal carcinoma based on an analysis of 13 cases from a single institution, with the aim of optimizing therapeutic approaches for treating patients with these rare tumors. Materials and methods. A retrospective analysis of data from 13 patients with nasopharyngeal adenocarcinoma treated at the N. N. Blokhin National Medical Research Center of Oncology from 1989 to 2023 was conducted. All patients underwent conservative chemoradiation therapy: in 6 cases – concurrent chemoradiation therapy, in 7 cases – induction chemotherapy followed by radiation or chemoradiation. Results. A complete clinical effect was achieved in 9 patients, a partial effect in 4. Disease progression was noted in 7 cases: local recurrence in 3 patients, continued tumor growth in 1, distant metastases in 3. The five-year survival rate was 38.5 %. Five patients died during the first two months, another three were lost to follow-up 5–15 months after the start of treatment. The median overall survival was 28 months. Conclusion. Adenoid cystic carcinoma of the nasopharynx is an extremely rare pathology. Although the standard treatment is surgery followed by radiation therapy, when radical surgery is not possible in patients with locally advanced disease, chemoradiation therapy becomes the treatment of choice.
- Open Access
- 18 March 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 15 (4) , 31-40
Surgical treatment of early-stage oropharyngeal cancer (T1–2N0–2bM0)
Introduction. Currently, oropharyngeal cancer is an important problem in oncology due to yearly morbidity growth. Most commonly, human papilloma virus-associated tumors are diagnosed. Tumors of the oropharynx are characterized by aggressive progression and high rate of regional metastases. The main 2 approaches to treatment of this pathology are surgical interventions on the primary lesion in the form of transoral interventions (laser microsurgery, robot-assisted interventions) or, less frequently, open surgeries, with subsequent observation, radiation / chemoradiation therapy per indications or chemoradiation therapy with surgical intervention in cases of residual tumor or locoregional recurrence. Both approaches allow to achieve high overall and recurrence-free survival but differ in complications and functional results. Aim. To evaluate efficacy of surgical treatment in the form of transoral surgical interventions in patients with early stage Т1–2N0–2bM0 oropharyngeal cancer. Materials and methods. The study included 120 patients with squamous cell carcinoma of the oropharynx Т1–2N0–2bM0 who underwent surgical treatment in the form of transoral surgical interventions. Results. Surgical treatment allowed to determine the exact stage of tumor process, form a group with high risk of disease progression, and formulate a plan of postoperative therapy which affected oncological outcomes. Conclusion. Surgical treatment of oropharyngeal cancer can serve as an independent option or be used in combination with other techniques and allows to achieve good oncological, functional and esthetic results, as well as to plan adjuvant therapy.
- 18 March 2026
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 15 (4) , 31-40
Open AccessSurgical treatment of early-stage oropharyngeal cancer (T1–2N0–2bM0)
Introduction. Currently, oropharyngeal cancer is an important problem in oncology due to yearly morbidity growth. Most commonly, human papilloma virus-associated tumors are diagnosed. Tumors of the oropharynx are characterized by aggressive progression and high rate of regional metastases. The main 2 approaches to treatment of this pathology are surgical interventions on the primary lesion in the form of transoral interventions (laser microsurgery, robot-assisted interventions) or, less frequently, open surgeries, with subsequent observation, radiation / chemoradiation therapy per indications or chemoradiation therapy with surgical intervention in cases of residual tumor or locoregional recurrence. Both approaches allow to achieve high overall and recurrence-free survival but differ in complications and functional results. Aim. To evaluate efficacy of surgical treatment in the form of transoral surgical interventions in patients with early stage Т1–2N0–2bM0 oropharyngeal cancer. Materials and methods. The study included 120 patients with squamous cell carcinoma of the oropharynx Т1–2N0–2bM0 who underwent surgical treatment in the form of transoral surgical interventions. Results. Surgical treatment allowed to determine the exact stage of tumor process, form a group with high risk of disease progression, and formulate a plan of postoperative therapy which affected oncological outcomes. Conclusion. Surgical treatment of oropharyngeal cancer can serve as an independent option or be used in combination with other techniques and allows to achieve good oncological, functional and esthetic results, as well as to plan adjuvant therapy.
- Open Access
- 1 July 2025
- Published by Publishing House ABV Press in Supportive Therapy in Oncology
- Vol. 2 (2) , 27-33
Current state and prospects of using low-energy laser radiation for early radiation damage in the treatment of head and neck tumors
Low-energy laser radiation, having anti-inflammatory, biostimulating and analgesic effects, can be used for the prevention and treatment of radiation erythema of the skin and post-radiation mucositis.We analyzed publications devoted to the use of laser therapy in patients with head and neck tumors undergoing radiation and chemoradiation therapy.To date, there are no standardized parameters for the technique of using laser radiation for preventive and therapeutic purposes in case of radiation damage to the skin and mucous membrane. All this requires further study of the parameters of using low-energy laser therapy, both for the treatment of radiation complications in patients with head and neck tumors, and for the prevention of the frequency and severity of early and late radiation injuries.
- 1 July 2025
- Published by Publishing House ABV Press in Supportive Therapy in Oncology
- Vol. 2 (2) , 27-33
Open AccessCurrent state and prospects of using low-energy laser radiation for early radiation damage in the treatment of head and neck tumors
Low-energy laser radiation, having anti-inflammatory, biostimulating and analgesic effects, can be used for the prevention and treatment of radiation erythema of the skin and post-radiation mucositis.We analyzed publications devoted to the use of laser therapy in patients with head and neck tumors undergoing radiation and chemoradiation therapy.To date, there are no standardized parameters for the technique of using laser radiation for preventive and therapeutic purposes in case of radiation damage to the skin and mucous membrane. All this requires further study of the parameters of using low-energy laser therapy, both for the treatment of radiation complications in patients with head and neck tumors, and for the prevention of the frequency and severity of early and late radiation injuries.
- Open Access
- 24 September 2024
- Published by Publishing House ABV Press in MD-Onco
- Vol. 4 (3) , 61-67
Factors affecting the effectiveness of conservative treatment of locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses
Background. Currently, the main method of treatment of locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses is surgical treatment with subsequent radiation/chemoradiation therapy. However, the survival rate of patients has not changed significantly in the last 20 years. Head and neck squamous cell carcinoma is highly sensitive to chemotherapy and radiation which allows to perform treatment even in cases of locally advanced squamous cell carcinomas of the nasal cavity and paranasal sinuses. However, the question of prognostic factors of the effect of chemoradiation therapy remains open. Therefore, determination of these factors is an important problem. Aim. To evaluate the effectiveness of conservative treatment of locally advanced squamous cell carcinoma of the nasal cavity and paranasalsinuses. Materials and methods. The retrospective analysis included 55 patients with squamous cell carcinoma of the nasal cavity and paranasal sinuses (stages III–IVA) who were under observation and receiving treatment at the N.N. Blokhin National Medical Research Center of Oncology between 2000 and 2020. In 50 (90.9 %) patients, treatment began with induction chemotherapy with subsequent radiation therapy per the radical program. In this patient group, treatment effectiveness was evaluated per the RECIST 1.1 (Response Evaluation Criteria In Solid Tumors) criteria. Results. Five-year overall and progression free survival rates were 49.5 and 22.5 %, respectively. Objective response rate after treatment was achieved in 65.5 % of cases: complete response was observed in 38.2 % of cases (n = 21); partial response in 27.3 % (n = 15); stable disease in 18.2 % of cases (n = 10); disease progression in 16.4 % (n = 9). Conclusion. According to the results of the study, conservative treatment is a promising approach in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses. Patients with complete response to treatment have the highest odds of cure and improved long-term outcomes.
- 24 September 2024
- Published by Publishing House ABV Press in MD-Onco
- Vol. 4 (3) , 61-67
Open AccessFactors affecting the effectiveness of conservative treatment of locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses
Background. Currently, the main method of treatment of locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses is surgical treatment with subsequent radiation/chemoradiation therapy. However, the survival rate of patients has not changed significantly in the last 20 years. Head and neck squamous cell carcinoma is highly sensitive to chemotherapy and radiation which allows to perform treatment even in cases of locally advanced squamous cell carcinomas of the nasal cavity and paranasal sinuses. However, the question of prognostic factors of the effect of chemoradiation therapy remains open. Therefore, determination of these factors is an important problem. Aim. To evaluate the effectiveness of conservative treatment of locally advanced squamous cell carcinoma of the nasal cavity and paranasalsinuses. Materials and methods. The retrospective analysis included 55 patients with squamous cell carcinoma of the nasal cavity and paranasal sinuses (stages III–IVA) who were under observation and receiving treatment at the N.N. Blokhin National Medical Research Center of Oncology between 2000 and 2020. In 50 (90.9 %) patients, treatment began with induction chemotherapy with subsequent radiation therapy per the radical program. In this patient group, treatment effectiveness was evaluated per the RECIST 1.1 (Response Evaluation Criteria In Solid Tumors) criteria. Results. Five-year overall and progression free survival rates were 49.5 and 22.5 %, respectively. Objective response rate after treatment was achieved in 65.5 % of cases: complete response was observed in 38.2 % of cases (n = 21); partial response in 27.3 % (n = 15); stable disease in 18.2 % of cases (n = 10); disease progression in 16.4 % (n = 9). Conclusion. According to the results of the study, conservative treatment is a promising approach in locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses. Patients with complete response to treatment have the highest odds of cure and improved long-term outcomes.
- Open Access
- 19 September 2024
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 7 (3) , 62-71
Intra-Arterial Chemotherapy for Locally Advanced Oral Cavity Cancer
Introduction: The standard treatment for locally advanced oral cavity cancer is surgery with followed by chemoradiotherapy Surgical treatment carries serious external and aesthetic risks and a long period of rehabilitation. On the other hand, standard chemoradiation treatment does not achieve adequate results. Intra-arterial chemotherapy is a promising treatment option. This method allows targeting the tumor to be while minimizing systemic factors and organ preservation, and the quality of life of the patients.Purpose: To compare the results of treatment of patients with locally advanced oral cancer using induction intra-arterial chemotherapy and surgical treatment at the first step.Material and methods: 62 patients were treated from 2017 to 2023 with locally advanced oral cancer. 23 patients underwent induction chemotherapy according to the DCF regimen with intra-arterial administration of cisplatin and docetaxel. In the second group, 39 patients underwent combined treatment with surgical treatment at the first step. The primary endpoint of the study was overall and disease-free survival. Secondary — objective response, treatment toxicity and the occurrence of prognostic factors in the intra-arterial chemotherapy group.Results: The duration of follow-up of patients in the intra-arterial group was 20.37 (CI 13.23–25.87) and in the surgery group 32.6 (CI 17.1–43.6) months. 1-year overall survival (OS) in the intra-arterial group and in the surgical group was 84.1 % and 69.2 % (p = 0.582), relapse-free survival (RFS) — 77.9 % and 62.5 % (p = 0.944). A subgroup analysis revealed an improvement in OS in patients treated with one arterial basin (p = 0.005). 1-year OS aſter induction chemotherapy for complete response, partial response, and stabilization were 90.9, 67.5, and 0 % (p < 0.001), respectively. 1-year RFS for complete response, partial response, and stabilization were 80, 76.2, and 0 % (p < 0.000), respectively.Conclusions: Intra-arterial chemotherapy has equivalent efficacy in terms of survival in patients with locally advanced tumors, oral cavity conclusion is indicated.
- 19 September 2024
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 7 (3) , 62-71
Open AccessIntra-Arterial Chemotherapy for Locally Advanced Oral Cavity Cancer
Introduction: The standard treatment for locally advanced oral cavity cancer is surgery with followed by chemoradiotherapy Surgical treatment carries serious external and aesthetic risks and a long period of rehabilitation. On the other hand, standard chemoradiation treatment does not achieve adequate results. Intra-arterial chemotherapy is a promising treatment option. This method allows targeting the tumor to be while minimizing systemic factors and organ preservation, and the quality of life of the patients.Purpose: To compare the results of treatment of patients with locally advanced oral cancer using induction intra-arterial chemotherapy and surgical treatment at the first step.Material and methods: 62 patients were treated from 2017 to 2023 with locally advanced oral cancer. 23 patients underwent induction chemotherapy according to the DCF regimen with intra-arterial administration of cisplatin and docetaxel. In the second group, 39 patients underwent combined treatment with surgical treatment at the first step. The primary endpoint of the study was overall and disease-free survival. Secondary — objective response, treatment toxicity and the occurrence of prognostic factors in the intra-arterial chemotherapy group.Results: The duration of follow-up of patients in the intra-arterial group was 20.37 (CI 13.23–25.87) and in the surgery group 32.6 (CI 17.1–43.6) months. 1-year overall survival (OS) in the intra-arterial group and in the surgical group was 84.1 % and 69.2 % (p = 0.582), relapse-free survival (RFS) — 77.9 % and 62.5 % (p = 0.944). A subgroup analysis revealed an improvement in OS in patients treated with one arterial basin (p = 0.005). 1-year OS aſter induction chemotherapy for complete response, partial response, and stabilization were 90.9, 67.5, and 0 % (p < 0.001), respectively. 1-year RFS for complete response, partial response, and stabilization were 80, 76.2, and 0 % (p < 0.000), respectively.Conclusions: Intra-arterial chemotherapy has equivalent efficacy in terms of survival in patients with locally advanced tumors, oral cavity conclusion is indicated.
- Open Access
- 3 August 2024
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 14 (2) , 48-56
Analysis of long-term results of conservative and surgical treatment in patients with locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses
Introduction. Surgical intervention with subsequent chemoradiation therapy is one of the treatment standards in squamous cell carcinoma of the nasal cavity and paranasal sinuses. However, the question of the optimal therapy for this pathology remains open.Aim. To compare treatment results in patients with locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses after conservative and surgical treatment.Materials and methods. The study included 86 patients with squamous cell carcinoma of the nasal cavity and paranasal sinuses, stages III–Iva, who between 2000 and 2020 received treatment at the N.N. Blokhin National medical Research Oncology Center. Surgical treatment with subsequent radiation or chemoradiation therapy was performed in 31 patients, conservative treatment (radiation or chemoradiation therapy) was performed in 55 patients.Results. Five-year overall survival in the conservative treatment group was 46.2 %, in the surgical treatment group – 59.7 % (р = 0.081); 5-year progression-free survival was 17 and 50.5 %, respectively (p = 0.002). In patients with Т3N0 tumor who received surgical treatment, 5-year progression-free survival was significantly higher than in patients who received conservative treatment (p 0,05). Comparison of overall survival and progression-free survival of patients who achieved objective response (complete response + partial response) after conservative treatment (n =36) and after surgical treatment (n = 31) did not show statistically significant differences (р = 0.469 and р = 0.183, respectively). The overall 5-year survival rate in the salvage surgery treatment group (24/55) was 63.1 % compared with 59.7 % in the surgical treatment group (n = 31), there were also no significant differences (p = 0.95). In patients with T3 tumor who received conservative treatment in this study, higher risk of progression was observed compared to patients who underwent surgical treatment.Conclusion. Surgical intervention remains an important treatment method for patients with locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses, especially in cases of smaller tumor extent. Conservative therapy seems promising but large-scale prospective controlled randomized clinical trials are necessary to confirm its effectiveness and safety in various patient groups.
- 3 August 2024
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 14 (2) , 48-56
Open AccessAnalysis of long-term results of conservative and surgical treatment in patients with locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses
Introduction. Surgical intervention with subsequent chemoradiation therapy is one of the treatment standards in squamous cell carcinoma of the nasal cavity and paranasal sinuses. However, the question of the optimal therapy for this pathology remains open.Aim. To compare treatment results in patients with locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses after conservative and surgical treatment.Materials and methods. The study included 86 patients with squamous cell carcinoma of the nasal cavity and paranasal sinuses, stages III–Iva, who between 2000 and 2020 received treatment at the N.N. Blokhin National medical Research Oncology Center. Surgical treatment with subsequent radiation or chemoradiation therapy was performed in 31 patients, conservative treatment (radiation or chemoradiation therapy) was performed in 55 patients.Results. Five-year overall survival in the conservative treatment group was 46.2 %, in the surgical treatment group – 59.7 % (р = 0.081); 5-year progression-free survival was 17 and 50.5 %, respectively (p = 0.002). In patients with Т3N0 tumor who received surgical treatment, 5-year progression-free survival was significantly higher than in patients who received conservative treatment (p 0,05). Comparison of overall survival and progression-free survival of patients who achieved objective response (complete response + partial response) after conservative treatment (n =36) and after surgical treatment (n = 31) did not show statistically significant differences (р = 0.469 and р = 0.183, respectively). The overall 5-year survival rate in the salvage surgery treatment group (24/55) was 63.1 % compared with 59.7 % in the surgical treatment group (n = 31), there were also no significant differences (p = 0.95). In patients with T3 tumor who received conservative treatment in this study, higher risk of progression was observed compared to patients who underwent surgical treatment.Conclusion. Surgical intervention remains an important treatment method for patients with locally advanced squamous cell carcinoma of the nasal cavity and paranasal sinuses, especially in cases of smaller tumor extent. Conservative therapy seems promising but large-scale prospective controlled randomized clinical trials are necessary to confirm its effectiveness and safety in various patient groups.
- Open Access
- 21 June 2023
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 6 (2) , 85-94
The Choice of Radiation Therapy Technology for Synchronous Primary Disseminated Breast Cancer
Radiation therapy of the primary tumor can be a stage of treatment of patients with initial IV stage breast cancer, being delievered out not only in purpose of decreasing symptom’s severity, but with an increase of progression-free survival.Modern technologies of radiation therapy, including intensity-modulated radiotherapy and radiation therapy with deep inspiration under the control of breathing (Respiratory Gating), can significantly reduce dose to risk organs and ensure a homogeneous isodose distribution in the irradiated area, which is especially important in patients receiving systemic treatment, which in itself has clinically significant cardio- and pulmonotoxicity.The presented clinical case demonstrates the possibility of dose reduction to organs at risk with usage of modern technologies of conformal radiation therapy.
- 21 June 2023
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 6 (2) , 85-94
Open AccessThe Choice of Radiation Therapy Technology for Synchronous Primary Disseminated Breast Cancer
Radiation therapy of the primary tumor can be a stage of treatment of patients with initial IV stage breast cancer, being delievered out not only in purpose of decreasing symptom’s severity, but with an increase of progression-free survival.Modern technologies of radiation therapy, including intensity-modulated radiotherapy and radiation therapy with deep inspiration under the control of breathing (Respiratory Gating), can significantly reduce dose to risk organs and ensure a homogeneous isodose distribution in the irradiated area, which is especially important in patients receiving systemic treatment, which in itself has clinically significant cardio- and pulmonotoxicity.The presented clinical case demonstrates the possibility of dose reduction to organs at risk with usage of modern technologies of conformal radiation therapy.
- Open Access
- 10 December 2022
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 12 (4) , 48-54
Experience of using a supraclavicular flap in reconstruction of oral cavity defects
Introduction. In case of cancer of the oral mucosa at the first stage, the standard treatment approach is radical surgical intervention, with the formation of extensive defects leading to aesthetic and functional disorders. Taking into account the characteristics of defects, choosing a flap is a difficult task. Currently, there is a wide selection of regional and microvascular free flaps. However, not all flaps meet the requirements. The supraclavicular fasciocutaneous flap, being a regional flap, has a number of advantages: easy to harvest, reliable due to the constancy of the vascular pedicle, primary closure of the donor site, scarcity of hair, the possibility of closing various defects of the oral cavity. Aim. To evaluate the possibility of using a supraclavicular flap in patients with oral cancer to restore the defects after surgical treatment.Materials and methods. The study included 10 patients with malignant tumors of the oral cavity who underwent surgical intervention with defect replacement using supraclavicular flap at the N. N. Blokhin National Medical Research Center of Oncology between February of 2015 and May of 2021. In 4 cases, buccal mucosa was affected; in 3 cases, the retromolar area; in 1 case, oral floor mucosa; in 1 case, mandibular alveolar ridge; in 1 case, mobile tongue. Flap sizes were 5–10 × 5–8 cm. Three (3) patients had history of radiotherapy, and 1 of them had a radical dose.Results. In 4 patients without previous radiotherapy, partial flap necrosis was observed. In 1 patient, sutural diastasis in the oral cavity after partial flap necrosis was diagnosed. There were no cases of total flap necrosis and fistula formation. Suture dehiscence in the donor bed was observed in 1 patient only.Conclusion. Use of supraclavicular flap is an option for oral cavity defect replacement after surgical intervention in patients with malignant tumors of the oral cavity producing satisfactory esthetic and functional results. The advantages of this flap are simple flap dissection, reliability of vascular pedicle, flexibility, possibility of replacing large defects, scant hair coverage.
- 10 December 2022
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 12 (4) , 48-54
Open AccessExperience of using a supraclavicular flap in reconstruction of oral cavity defects
Introduction. In case of cancer of the oral mucosa at the first stage, the standard treatment approach is radical surgical intervention, with the formation of extensive defects leading to aesthetic and functional disorders. Taking into account the characteristics of defects, choosing a flap is a difficult task. Currently, there is a wide selection of regional and microvascular free flaps. However, not all flaps meet the requirements. The supraclavicular fasciocutaneous flap, being a regional flap, has a number of advantages: easy to harvest, reliable due to the constancy of the vascular pedicle, primary closure of the donor site, scarcity of hair, the possibility of closing various defects of the oral cavity. Aim. To evaluate the possibility of using a supraclavicular flap in patients with oral cancer to restore the defects after surgical treatment.Materials and methods. The study included 10 patients with malignant tumors of the oral cavity who underwent surgical intervention with defect replacement using supraclavicular flap at the N. N. Blokhin National Medical Research Center of Oncology between February of 2015 and May of 2021. In 4 cases, buccal mucosa was affected; in 3 cases, the retromolar area; in 1 case, oral floor mucosa; in 1 case, mandibular alveolar ridge; in 1 case, mobile tongue. Flap sizes were 5–10 × 5–8 cm. Three (3) patients had history of radiotherapy, and 1 of them had a radical dose.Results. In 4 patients without previous radiotherapy, partial flap necrosis was observed. In 1 patient, sutural diastasis in the oral cavity after partial flap necrosis was diagnosed. There were no cases of total flap necrosis and fistula formation. Suture dehiscence in the donor bed was observed in 1 patient only.Conclusion. Use of supraclavicular flap is an option for oral cavity defect replacement after surgical intervention in patients with malignant tumors of the oral cavity producing satisfactory esthetic and functional results. The advantages of this flap are simple flap dissection, reliability of vascular pedicle, flexibility, possibility of replacing large defects, scant hair coverage.
- Open Access
- 22 September 2022
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 5 (3) , 63-69
The Effect of Radiation Therapy on the Success of the Use of Submental Flap in the Reconstruction of Oral Cavity Defects
Purpose: To evaluate the effect of previously performed radiation therapy on the successful use of a submental flap in oral reconstruction. Material and methods: The study included 52 patients who underwent reconstruction of oral cavity defects using a submental flap between February 2015 and January 2021. Radiation therapy was performed in 13 patients in the preoperative period at different time periods and in different doses. Results: From February 2015 to August 2021, to 52 patients submental flap was used to reconstruct oral cavity defects after surgical treatment of oral mucosal cancer. 13 patients received radiation therapy before surgical treatment compared to 39 who did not. In eleven cases, partial flap necrosis occurred, of which 3 underwent radiation therapy to two in a radical dose before surgical treatment. In two cases, there was a discrepancy of sutures in the oral cavity, one in each group, which did not require surgical intervention and were closed with conservative treatment. Two patients who underwent radiation therapy developed a fistula communicating with the oral cavity and neck healed spontaneously with conservative management. Marginal mandibular nerve palsy developed in three patients, one in the group with radiation therapy, the rest without a history of radiation therapy. Conclusions: Total flap necrosis was not observed in any group. Thus, preoperative radiation therapy is not a contraindication to the use of a submental flap to reconstruct oral cavity defects with relatively acceptable complications. The submental flap is easy to harvest, reliable, universal flap to reconstruct oral cavity defects.
- 22 September 2022
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 5 (3) , 63-69
Open AccessThe Effect of Radiation Therapy on the Success of the Use of Submental Flap in the Reconstruction of Oral Cavity Defects
Purpose: To evaluate the effect of previously performed radiation therapy on the successful use of a submental flap in oral reconstruction. Material and methods: The study included 52 patients who underwent reconstruction of oral cavity defects using a submental flap between February 2015 and January 2021. Radiation therapy was performed in 13 patients in the preoperative period at different time periods and in different doses. Results: From February 2015 to August 2021, to 52 patients submental flap was used to reconstruct oral cavity defects after surgical treatment of oral mucosal cancer. 13 patients received radiation therapy before surgical treatment compared to 39 who did not. In eleven cases, partial flap necrosis occurred, of which 3 underwent radiation therapy to two in a radical dose before surgical treatment. In two cases, there was a discrepancy of sutures in the oral cavity, one in each group, which did not require surgical intervention and were closed with conservative treatment. Two patients who underwent radiation therapy developed a fistula communicating with the oral cavity and neck healed spontaneously with conservative management. Marginal mandibular nerve palsy developed in three patients, one in the group with radiation therapy, the rest without a history of radiation therapy. Conclusions: Total flap necrosis was not observed in any group. Thus, preoperative radiation therapy is not a contraindication to the use of a submental flap to reconstruct oral cavity defects with relatively acceptable complications. The submental flap is easy to harvest, reliable, universal flap to reconstruct oral cavity defects.